{"changes":[{"companyHref":"/c/bonumtx-com","date":"2026-09-25","documentUrl":null,"domain":"bonumtx.com","fact":"latest round","name":"Bonum Therapeutics, Inc.","new":{"amountUsd":26900000,"date":"2026-04-03","lead":null,"type":null},"old":{"amountUsd":26900000,"date":"2026-04-03","lead":null,"type":"seed"},"publisher":"sec-edgar","reason":null,"retrievedAt":"2026-05-05","slug":"bonumtx-com","status":"attributed","url":"https://whoraisedwhat.com/c/bonumtx-com"}],"country":"US","description":"Antibody-controlled therapeutics with dual-binding antibodies that stay inactive until they encounter their target, focused on regulated cytokines. Targets oncology with extensions into autoimmune, metabolic, and pain indications. Differentiated by activity-on-binding antibody chemistry rather than payload chemistry.","domain":"bonumtx.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":47.603832,"lng":-122.330062,"location":"Seattle, WA, USA","name":"Bonum Therapeutics, Inc.","rounds":[{"amountQuarantined":false,"amountUsd":26900000,"currency":"USD","date":"2026-04-03","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-05-05","status":"attributed","url":null},"status":"attributed","type":null,"url":null}],"slug":"bonumtx-com","sources":[{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-05-05","status":"attributed","url":null},{"fact":"existence","publisher":"bonumtx.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://bonumtx.com"},{"fact":"description","publisher":"bonumtx.com","retrievedAt":"2026-05-05","status":"self-reported","url":"https://bonumtx.com"}],"stage":null,"techStack":["Cloudflare","WordPress","Yoast SEO 27.6","Google Tag Manager","imagesLoaded 5.0.0","cdnjs","Cloudflare Bot Management","CookieYes","PHP","MySQL"],"totalRaisedUsd":26900000,"updatedAt":"2026-05-05"}